Peter Lloyd
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Immunology 14
- Biosimilars and Bioanalytical Methods 5
- Co-authors
- Bin Peng (3 shared papers)Horst Schran (1 shared paper)Gérard Flesch (4 shared papers)Philipp Müller (1 shared paper)Renaud Capdeville (2 shared papers)Michael Hayes (2 shared papers)Reid Rubsamen (9 shared papers)W. Dieterle (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (4 papers)Clinical Pharmacology & Therapeutics (4 papers)The Journal of Clinical Pharmacology (3 papers)Vaccine (2 papers)Biopharmaceutics & Drug Disposition (2 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Peter Lloyd
51 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Hematology 802
- Genetics 552
- Gastroenterology 171
- Pharmaceutical Science 187
- Rheumatology 393
Countries citing papers authored by Peter Lloyd
This map shows the geographic impact of Peter Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lloyd more than expected).
Fields of papers citing papers by Peter Lloyd
This network shows the impact of papers produced by Peter Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lloyd. The network helps show where Peter Lloyd may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Lloyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Pharmacokinetics of Imatinib Hit paper breakdown → | 2005 | 513 |
| 2 | 2004 | 371 | |
| 3 | 1997 | 173 | |
| 4 | Formation Imaging With Microelectrical Scanning Arrays | 1986 | 149 |
| 5 | 2004 | 131 | |
| 6 | 1994 | 121 | |
| 7 | 1995 | 116 | |
| 8 | 1991 | 104 | |
| 9 | 2009 | 88 | |
| 10 | 1997 | 77 | |
| 11 | 1997 | 62 | |
| 12 | 2009 | 62 | |
| 13 | 2004 | 59 | |
| 14 | 2006 | 53 | |
| 15 | 1997 | 50 | |
| 16 | 2009 | 49 | |
| 17 | 2012 | 44 | |
| 18 | 2016 | 42 | |
| 19 | 2000 | 41 | |
| 20 | 2022 | 40 |
About Peter Lloyd
Peter Lloyd is a scholar working on Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine, having authored 52 papers that have together received 2.9k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Inhalation and Respiratory Drug Delivery (9 papers), Biosimilars and Bioanalytical Methods (5 papers), Blood Pressure and Hypertension Studies (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Epilepsy research and treatment (4 papers), Analytical Methods in Pharmaceuticals (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Hematology (802 citations), Genetics (552 citations), Gastroenterology (171 citations), Pharmaceutical Science (187 citations) and Rheumatology (393 citations). Peter Lloyd has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Bin Peng, Horst Schran, Gérard Flesch, Philipp Müller, Renaud Capdeville, Michael Hayes, Reid Rubsamen, W. Dieterle, Charles L. Sawyers and Marianne Rosamilia. Their work appears in journals such as British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology, Vaccine and Biopharmaceutics & Drug Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.